Shattuck Labs, Inc.
NASDAQ:STTKBiotechnology
+$0.11 today
- Market cap
- $463.38M
- Beta
- 1.09
- P/E (TTM)
- -10.9
- EPS (TTM)
- -$0.44
Volume 1.39M
Average 0.69M
Returns on capital
Shattuck Labs, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-59.2%
avg -20.6%
ROIC
-60.7%
avg -52.2%
ROA
-53.6%
avg -41.3%
Analysis
ROA is currently the strongest return metric at -53.6% versus its period average of -41.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Taylor H. Schreiber | Co-Founder, Chief Executive Officer & Director | USD 876.23K | 46 | — | — |
Arundathy Nirmalini Pandite | Chief Medical Officer | USD 734.9K | 67 | — | — |
Andrew R. Neill | Chief Financial Officer | USD 678.21K | 40 | 0 | <0.01% |
Abhinav A. Shukla | Chief Technical Officer | USD 567.4K | 53 | 14.14K | 0.03% |
Casi DeYoung | Chief Business Officer | USD 523.48K | 55 | 73.48K | 0.15% |
Stephen Stout | General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | — | 51 | 0 | <0.01% |
Thomas Lampkin | Senior Vice President of Regulatory Affairs | — | — | — | — |
Suresh de Silva | Chief Scientific Officer | — | — | — | — |
Kelli Collin | Senior Vice President of Quality | — | — | — | — |
Brad Huckabee | Vice President of Accounting & SEC reporting | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jul 6, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
5
$250,250.00
Sells
6
$591,849.62
Net Transaction Value
−$341,599.62
Net selling
Most Active
Shukla Abhinav A.
4 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Jul 2, 26Jul 2, 2026 | Shukla Abhinav A. Direct | Sell | $2.9K$2,874.10 |
| Jul 1, 26Jul 1, 2026 | Shukla Abhinav A. Direct | Sell | $707$707.00 |
| Jun 30, 26Jun 30, 2026 | Shukla Abhinav A. Direct | Sell | $165.4K$165,424.20 |
| Jun 30, 26Jun 30, 2026 | Pandite Arundathy N. Direct | Sell | $210.3K$210,300.00 |
| Jun 11, 26Jun 11, 2026 | ORBIMED ADVISORS LLC Indirect | Buy | $104.2$104.17 |
| Jun 11, 26Jun 11, 2026 | Ashiya Mona Indirect | Buy | $104.2$104.17 |
| Jun 11, 26Jun 11, 2026 | Ashiya Mona Indirect | Buy | $20.8$20.83 |
| Jun 11, 26Jun 11, 2026 | ORBIMED ADVISORS LLC Indirect | Buy | $20.8$20.83 |
| Jun 9, 26Jun 9, 2026 | SIEGALL CLAY B Direct | Buy | $250K$250,000.00 |
| May 12, 26May 12, 2026 | Shukla Abhinav A. Direct | Sell | $14.2K$14,244.32 |
1–10 of 11
Summary
Insiders reported 5 buys worth $250,250.00 and 6 sells worth $591,849.62 over the last 12 months. That adds up to net selling of $341,599.62. Shukla Abhinav A. was the most active insider with 4 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A3 analysts |
| Revenue | N/A | N/A | +15.3% | -8.3% (5yr)6 analysts |
| Net Income | N/A | N/A | N/A | N/A6 analysts |
| EBIT | N/A | N/A | N/A | N/A6 analysts |
Analysis
Recent growth has been strongest in Revenue at +15.3% over three years. Forward estimates point to Revenue at -8.3% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Shattuck Labs, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about STTK's management, answered from reported figures.
Who manages STTK?
Shattuck Labs, Inc. (STTK) lists 10 active executives. The top listed executive is Abhinav A. Shukla, Chief Technical Officer.
Are STTK insiders buying or selling?
Recent insider activity shows net buying of $81.96M.
Continue the stock analysis
Jump to another research area for this company.